根据母体因素和妊娠11-13周生物标志物筛查双胎妊娠子痫前期的竞争风险模型
本研究在1100例双胎妊娠和35948例单胎妊娠中,于妊娠11-13周联合母体因素、子宫动脉搏动指数、平均动脉压、妊娠相关血浆蛋白A和胎盘生长因子筛查子痫前期。双胎中联合筛查可检出几乎所有病例,但假阳性率高达75%。
要点
- 双胎妊娠子痫前期患者MAP和UtA-PI升高,PlGF和PAPP-A降低。
- 联合母体因素、MAP、UtA-PI和PlGF可提高筛查性能,加PAPP-A无进一步改善。
- 双胎中联合筛查检出率近100%,但筛查阳性率高达75%。
核心结论
- 单胎妊娠的早孕期联合筛查模型可调整用于双胎妊娠子痫前期筛查,能检出几乎所有病例但筛查阳性率高。
研究设计与样本
- 筛查研究,纳入1100例双胎妊娠和35948例单胎妊娠,于妊娠11-13周应用贝叶斯定理结合母体因素先验风险与UtA-PI、MAP、PAPP-A和PlGF的MoM值。
主要发现
- 双胎妊娠发生子痫前期者MAP和UtA-PI值升高,PlGF和PAPP-A值降低。
- 生物标志物log10 MoM值随分娩孕周的分布与既往单胎报道相似,故假设同一模型可用于单胎和双胎。
- 母体因素联合MAP、UtA-PI和PlGF可改善筛查性能,加PAPP-A无进一步改善。
- 在混合人群中,风险截断值1/75筛查<37周子痫前期,单胎<32、<37和<42周检出率分别为91%、77%和57%,筛查阳性率13%;双胎相应检出率为100%、99%和97%,筛查阳性率75%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a model for screening for pre-eclampsia (PE) in twin pregnancies based on maternal demographic characteristics and medical history and biomarkers at 11-13 weeks' gestation. METHODS: This was a screening study in twin pregnancies at 11-13 weeks' gestation. Bayes theorem was used to combine the a-priori risk from maternal factors with various combinations of uterine artery pulsatility index (UtA-PI), mean arterial pressure (MAP), serum pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF) multiples of the median (MoM) values. The performance of screening for PE requiring delivery at < 32, < 37 and < 42 weeks' gestation was estimated in 1100 twin pregnancies and 35 948 singleton pregnancies with complete data on UtA-PI, MAP, PlGF and PAPP-A. RESULTS: In twin pregnancies that developed PE, the values of MAP and UtA-PI were increased and the values of PlGF and PAPP-A were decreased. The distributions of log10 MoM values of biomarkers with gestational age at delivery were similar to those that were previously reported in singleton pregnancies and it was therefore assumed that the same model could be used for both singleton and twin pregnancies. The performance of screening for PE by maternal factors was improved by the addition of MAP, UtA-PI and PlGF; there was no further improvement with the addition of PAPP-A. In a mixed population of singleton and twin pregnancies, combined screening by maternal factors, MAP, UtA-PI and PlGF and risk cut-off of 1 in 75 for PE at < 37 weeks, the detection rate of PE at < 32, < 37 and < 42 weeks in singleton pregnancies was 91%, 77% and 57%, respectively, at a screen-positive rate (SPR) of 13%; the respective rates for twin pregnancies were 100%, 99% and 97%, at a SPR of 75%. CONCLUSION: First-trimester combined screening for PE in singleton pregnancies can be adapted for screening in twins, leading to detection of nearly all affected cases but at a high SPR. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Francisco C, Wright D, Benkő Z, et al. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2017. PMID: 28556556. doi:10.1002/uog.17531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。